Skip to main content
stock analysisgrowth stocksAI infrastructurefundamental analysisearnings analysis

CRWV: $66B Backlog Meets $15B Debt Problem

ByThe PragmatistBalanced analysis. Clear recommendations.
·7 min read
Share:

Key Takeaways

  • CoreWeave's Q4 2025 revenue hit $1.57 billion with 110% year-over-year growth, but gross margins compressed from 73% to 67.6% quarter-over-quarter.
  • The $66.8 billion backlog (up 342% YoY) provides over 12 years of revenue visibility at current run rates.
  • Debt of $15.5 billion and negative free cash flow of $7.25 billion make additional capital raises near-certain, risking further dilution at depressed share prices.
  • Analysts expect profitability by 2028 at $0.67 EPS — the May 13 earnings report is the next major catalyst.

$66.8 billion in contracted backlog and 110% year-over-year revenue growth sound like the foundation of a generational infrastructure play. CoreWeave's Q4 2025 revenue hit $1.57 billion, cementing the GPU cloud provider as the fastest-growing name in AI infrastructure. The stock tells a different story: at $69.40, CRWV sits 63% below its 52-week high of $187 and trades below both its 50-day ($88.56) and 200-day ($108.36) moving averages.

The bear case writes itself. CoreWeave burned $7.25 billion in free cash flow last year, carries roughly $15.5 billion in debt at a 4.5x debt-to-equity ratio, and posted a $1.17 billion net loss in 2025. Interest expense alone ran $388 million in Q4 — nearly 25% of quarterly revenue consumed by debt service. Insider selling triggered an 8.1% drop on March 27, adding fuel to the skeptics.

The bull case is equally compelling. That $66.8 billion backlog (up 342% year-over-year) represents over 12 years of current revenue locked in. Revenue is projected to reach $7.4-9.5 billion by 2028, with analysts expecting profitability by then at $0.67 consensus EPS. CoreWeave is building the picks-and-shovels infrastructure for the AI boom. The question is whether it can survive long enough to collect.

Valuation: Expensive on Earnings, Cheaper on Revenue

CoreWeave's PE ratio of -24.7 is meaningless for a pre-profit company. The metrics that matter: a price-to-sales ratio of 7.1x trailing (based on $5.13 billion FY2025 revenue and $36.5 billion market cap), and an EV/EBITDA of 57.1x.

The P/S compression has been dramatic. In Q3, the stock traded at 49.9x sales. By Q4, the combination of revenue growth and share price decline brought that to 19.8x on a quarterly annualized basis. The trailing annual figure at 7.1x starts to look reasonable for a company growing revenue at triple-digit rates — but only if that growth sustains.

For context, Nebius — CoreWeave's emerging competitor in GPU cloud — trades at similar revenue multiples with less debt. The 57.1x EV/EBITDA is steep but reflects $742 million in quarterly EBITDA at a 47% margin. If CoreWeave scales revenue to $9 billion by 2028 while maintaining that EBITDA margin, the current enterprise value implies roughly 12x forward EV/EBITDA. That is the entire bull thesis compressed into one ratio.

Earnings: Revenue Accelerating, Losses Persistent

CoreWeave's quarterly revenue trajectory is hard to ignore. From $982 million in Q1 to $1.21 billion in Q2, $1.36 billion in Q3, and $1.57 billion in Q4, the company delivered consistent sequential acceleration throughout 2025. Full-year revenue reached $5.13 billion, up from roughly $2 billion the prior year.

The problem sits below the revenue line. Gross margin slipped from 73% in Q3 to 67.6% in Q4, suggesting pricing pressure or a shift toward lower-margin workloads as the customer base expands. The Zonos enterprise contract win demonstrates recurring revenue momentum, but enterprise deals typically carry thinner margins than hyperscaler arrangements.

Net loss widened to $452 million in Q4 (EPS -$0.89), bringing the full-year loss to $1.17 billion. Depreciation and amortization of $821 million in Q4 dwarfs the operating loss of $90 million, which means the business is operationally close to breakeven on a cash-adjusted basis. EBITDA of $742 million at a 47% margin confirms this — CoreWeave generates real operating cash flow. The losses are an accounting artifact of massive capital deployment, not a broken business model.

Financial Health: The Debt Elephant

CoreWeave's balance sheet is the single biggest risk factor. Total debt of approximately $15.5 billion against a 4.5x debt-to-equity ratio makes this one of the most leveraged names in tech. Interest expense of $388 million in Q4 alone means the company pays $1.5 billion annually just to service its debt — roughly 30% of 2025 revenue.

Operating cash flow of $3.06 billion provides a cushion, but capital expenditure of $10.3 billion produced free cash flow of negative $7.25 billion in 2025. The company ended the year with $3.95 billion in cash, which covers roughly six months of the cash burn gap between operating cash flow and capex.

ROE of -13.5% and stock-based compensation running at 10% of revenue add further dilution pressure. CoreWeave will almost certainly need additional capital raises — debt or equity — to fund its GPU buildout through 2027. At current share prices, equity issuance would be brutally dilutive. At current rates, additional debt would compound an already precarious leverage position.

The saving grace: that $66.8 billion backlog provides lenders with visibility on future cash flows. As long as hyperscalers and enterprises honor those contracts, CoreWeave can roll its debt forward. The risk is a demand shock — if AI spending decelerates, those contracts could face renegotiation pressure.

Growth and Competition

CoreWeave occupies a specific niche: purpose-built GPU cloud infrastructure for AI training and inference workloads. Unlike AWS, Azure, or GCP, which offer GPU compute alongside hundreds of other services, CoreWeave focuses exclusively on GPU-optimized infrastructure. This specialization delivers performance advantages and has attracted major customers including Microsoft.

The 342% surge in backlog to $66.8 billion validates demand. But the competitive landscape is shifting. Nebius (spun out from Yandex) is building GPU cloud infrastructure with a similar playbook and less debt. The hyperscalers themselves are investing hundreds of billions in GPU capacity — Google, Amazon, and Microsoft each plan $60-80 billion in AI capex for 2025-2026. As this capacity comes online, CoreWeave's pricing power faces structural headwinds.

The Zonos contract win matters because it represents the next phase: enterprise AI adoption beyond the hyperscaler cohort. If CoreWeave can capture recurring enterprise workloads — inference, fine-tuning, private deployments — the revenue base diversifies beyond a handful of massive contracts. The 110% year-over-year revenue growth in Q4 suggests this diversification is underway, but customer concentration data remains limited.

Forward Outlook: Path to Profitability or Capital Trap?

Analyst consensus points to profitability by 2028 at $0.67 EPS, with revenue reaching $7.4-9.5 billion. That implies CoreWeave roughly doubles revenue from 2025 while swinging from a $1.17 billion net loss to positive earnings. The path runs through operating leverage: if revenue scales against a fixed-ish debt and depreciation base, margins expand rapidly.

The next earnings announcement on May 13, 2026 will be critical. Investors need to see three things: gross margin stabilization above 65%, capex intensity declining as a percentage of revenue, and backlog conversion into recognized revenue. Any deterioration in these metrics will validate the bear thesis that CoreWeave is a capital-destruction machine.

Insider selling remains a concern. The March 27 episode — which triggered an 8.1% single-day decline — signals that at least some insiders view current prices as an acceptable exit point. At $69.40, the stock trades at roughly 5x the midpoint of its IPO range, which may represent a natural profit-taking level for early investors rather than a fundamental signal.

The stock's position 63% below its 52-week high and 21% below its 50-day average reflects deep skepticism. For a contrarian buyer, this is precisely when asymmetric bets are made. For a risk-averse investor, the debt load, negative free cash flow, and insider selling are a triple warning.

Conclusion

CoreWeave is not a stock — it is a leveraged bet on the duration and intensity of the AI infrastructure cycle. The $66.8 billion backlog and 110% revenue growth rate are extraordinary. The $15.5 billion in debt, $7.25 billion in negative free cash flow, and persistent net losses are equally extraordinary in the other direction.

Aggressive growth investors with a 3-5 year horizon and tolerance for 50%+ drawdowns can build a position below $70, treating this as a high-conviction, high-risk allocation capped at 2-3% of a portfolio. Conservative investors and anyone relying on their portfolio for near-term income should stay away entirely. The May 13 earnings report is the next catalyst — wait for margin and cash flow data before adding to any position.

Frequently Asked Questions

Sources & References

Enjoyed this article?
Share:

Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.

Explore More

Related Articles